GlucoTrack, Inc. (NASDAQ:GCTK) Short Interest Up 217.6% in February

GlucoTrack, Inc. (NASDAQ:GCTK) was the recipient of a large growth in short interest in February. As of February 15th, there was short interest totalling 104,500 shares, a growth of 217.6% from the January 31st total of 32,900 shares. Approximately 1.0% of the shares of the stock are sold short. Based on an average daily trading volume, of 3,380,000 shares, the days-to-cover ratio is presently 0.0 days.

Institutional Inflows and Outflows

An institutional investor recently raised its position in GlucoTrack stock. Geode Capital Management LLC lifted its position in shares of GlucoTrack, Inc. (NASDAQ:GCTK) by 315.3% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 112,787 shares of the company’s stock after buying an additional 85,626 shares during the period. Geode Capital Management LLC owned approximately 14.10% of GlucoTrack worth $42,000 as of its most recent filing with the Securities and Exchange Commission (SEC). 10.92% of the stock is owned by institutional investors.

GlucoTrack Price Performance

GlucoTrack stock traded up $0.01 during midday trading on Friday, reaching $0.36. The company had a trading volume of 570,381 shares, compared to its average volume of 5,653,275. The company has a market capitalization of $3.76 million, a P/E ratio of -0.01 and a beta of -0.38. GlucoTrack has a 12-month low of $0.33 and a 12-month high of $99.00. The firm’s fifty day simple moving average is $2.25 and its 200-day simple moving average is $22.29.

GlucoTrack Company Profile

GlucoTrack, Inc, a medical device company, focused on the design, development, and commercialization of novel technologies for people with diabetes in the United States. It develops GlucoTrack, a noninvasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain.